Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

DANIEL LEBOVIC

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1740302850
CMS profile
169543
Location
GROSSE POINTE WOODS, MI

General Payments · PY2018–2024

$394,596.62

  • Reported across 345 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$23,936.23

19 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
GENZYME CORPORATION $8,324.26 5
Genentech USA, Inc. $5,815.00 3
ABBVIE INC. $4,750.01 3
Amgen Inc. $3,300.00 1
PharmaEssentia USA Corporation $1,540.00 1
Janssen Biotech, Inc. $87.28 1
Merck Sharp & Dohme Corporation $32.53 1
EISAI INC. $26.42 1
GlaxoSmithKline, LLC. $21.10 1
SOBI, INC $21.06 1
Genmab U.S., Inc. $18.57 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $64,384.63 86
PY2019 $98,314.47 111
PY2020 $47,290.71 31
PY2021 $62,087.78 32
PY2022 $55,911.76 36
PY2023 $42,671.04 30
PY2024 $23,936.23 19

Payment records · PY2024 (19)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $2,375.00 09/10/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1103160214 CMS
ABBVIE INC. $0.01 12/03/2024 Food and Beverage Undisputed 01/23/2026 1104148866 CMS
ABBVIE INC. $2,375.00 12/24/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1103160216 CMS
Amgen Inc. $3,300.00 03/25/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1111630684 CMS
Eisai Inc. $26.42 01/15/2024 Food and Beverage Undisputed 01/23/2026 1110738809 CMS
Genentech USA, Inc. $2,530.00 01/17/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1132994191 CMS
Genentech USA, Inc. $1,765.00 05/17/2024 Consulting Fee Undisputed 01/23/2026 1132994199 CMS
Genentech USA, Inc. $1,520.00 11/21/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1132994195 CMS
Genmab U.S., Inc. $18.57 05/21/2024 Food and Beverage Undisputed 01/23/2026 1126825719 CMS
GENZYME CORPORATION $1,338.00 07/09/2024 Consulting Fee Undisputed 01/23/2026 1139780470 CMS
GENZYME CORPORATION $535.00 10/09/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1139780490 CMS
GENZYME CORPORATION $3,478.00 11/13/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1139780480 CMS
GENZYME CORPORATION $30.26 11/14/2024 Food and Beverage Undisputed 01/23/2026 1139780492 CMS
GENZYME CORPORATION $2,943.00 11/14/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1139780494 CMS
GlaxoSmithKline, LLC. $21.10 09/17/2024 Food and Beverage Undisputed 01/23/2026 1116655841 CMS
Janssen Biotech, Inc. $87.28 10/30/2024 Food and Beverage Undisputed 01/23/2026 1078773286 CMS
Merck Sharp & Dohme LLC $32.53 11/14/2024 Food and Beverage Undisputed 01/23/2026 1141830712 CMS
PharmaEssentia USA Corporation $1,540.00 09/12/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1137310402 CMS
SOBI, INC $21.06 07/03/2024 Food and Beverage Undisputed 01/23/2026 1141424999 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.